Indeed, our results show that therapeutical inhibition of active GzmA with serpinb6b similarly increased survival in WT and GzmK -/- mice and reduced IL-6 serum levels, confirming the potential of GzmA as a therapeutic target for sepsis treatment 15. The gene discussed is GZMK; the disease is Sepsis.